Skip to reading
BoiseAn Idaho peptide notebook
Chapter index

Boise, Idaho · Check / Made-to-order medicine

Made to order does not mean FDA approved.

Ask why it is being prepared and which rules apply.

Facts checked in September 2026; this is the check date, not when a rule began.

Blank cream index sheets, a green paper circle, and a lime corner marker.
Read the record. Ask the next question.

The assumption to check

Does a custom medicine have the same review as a finished drug?

A clearer starting point

Ask why it is being prepared and which rules apply.

What compounding means

The Food and Drug Administration (FDA) regulates drugs in the US.

The FDA describes compounding as preparing a medicine through a pharmacist, doctor, or registered facility rather than supplying an approved finished product.

The FDA says, as of September 2026, that compounding can help patients when an approved medicine cannot meet their needs or the approved product is unavailable.

Ask the clinician to explain the need in your case. Keep that answer separate from the price comparison.

What has not been reviewed

Compounded medicines lack FDA approval. For compounded medicines, the FDA does not review safety, how well they work, or the quality of preparation before sale (checked September 2026).

Ask what evidence supports this exact made-to-order medicine. A claim that it has the same evidence as a ready-made drug needs an explanation.

Made for you, or made in a batch?

Federal law calls the route for a pharmacy or doctor preparing a named patient’s medicine 503A. It needs a valid prescription with that patient’s name. Other rules also apply; the prescription alone is not enough (checked September 2026).

Another route, called 503B, lets an FDA-registered maker prepare batches of sterile medicines, meaning free of living germs. This maker is called an outsourcing facility. It need not get a prescription naming each patient before making the batch (checked September 2026).

You do not have to choose between these kinds of maker yourself. Ask who made your medicine and which route they used.

For the 503A route, federal law also limits regular copying of a medicine already available (checked September 2026).

An Idaho check still matters

As of September 2026, Idaho requires compounders to get active ingredients, the parts that do the work, from FDA-registered manufacturers. They must keep the required ingredient records.

  • What patient need does this preparation meet?
  • Which pharmacy or facility makes it?
  • What evidence applies to this exact preparation?
  • What written information will I receive?